A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy Subjects

Trial Identifier: D5671C00009
Sponsor: AstraZeneca
Collaborator:
Quotient Sciences Ltd
NCTID:: NCT05294458
Start Date: March 2022
Primary Completion Date: May 2022
Study Completion Date: May 2022
Condition: Chronic Kidney Diseases; Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
GB Ruddington, GB, NG11 6JS